Skip to main content

Utah Medical Marijuana Campaign Funding Slows Down Following Compromise Deal

Major late contributions are flowing into the coffers of Michigan and Missouri political action committees that have been set up to support or oppose marijuana ballot initiatives in those states, Marijuana Moment’s latest analysis of campaign finance data shows.

In Missouri, physician Bradley Bradshaw continues to pour money into the Find the Cures committee in support of Amendment 3. For October, since filing quarter three reports, the group reports $343,000 in contributions from Bradshaw in the form of loans. He had contributed $7,500 in cash in quarter three, and also provided $186,121 in loans. Find the Cures is also getting late support from legal firms, with five outfits contributing $45,000.

New Approach Missouri, which supports Amendment 2, reported that it had received $125,000 from Washington, D.C.-based New Approach PAC.

A committee set up to combat Bradshaw’s Measure 3, Patients Against Bradshaw Amendment Formally Known As Find The Cures Political Action Committee, reported only $757 in contributions in a filing made on Monday. Missourians For Patient Care reported no cash contributions in its “8 days before election” report, but disclosed a $450 contribution in a late contribution report.

In Michigan, the two largest marijuana initiative committees have seen a quarter-million dollars in contributions in just the last three days since quarter three figures were filed on Friday. The pro-legalization Coalition to Regulate Marijuana Like Alcohol officially reported a $25,000 donation that had been announced last week by the Drug Policy Alliance. National group New Approach is also a force here, donating an additional $58,650 to the committee over the weekend, bringing their October contributions in the state to over $300,000.

Meanwhile, the largest committee working against the initiative, Healthy and Productive Michigan, is reporting a sizable new contribution of $75,000 from national prohibition organization Smart Approaches to Marijuana, which has already provided over $1 million in cash and in-kind services to the effort. The prohibitionist committee also reported $100,000 from Dow Chemical Corporation.

DTE Energy executives continued to weigh in against the initiative, with David Meador, vice chairman of DTE Energy, and David Ruud, president of DTE Power & Industrial, each giving $2,500 to the anti-legalization committee. The group had already reported a total of $70,000 in donations from DTE Energy Chairman Gerard Anderson, company President and COO Jerry Norcia, DTE Electric President Trevor Lauer and DTE Gas President Mark Stiers.

In total, Healthy and Productive Michigan has racked up $310,000 in late contributions since October 20, while the Coalition to Regulate Marijuana Like Alcohol has brought in $151,150. For each committee, these new donations in the last nine days equal about one-third of their total cash previously raised in all of quarter three (August 20 – October 20).

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!

Original Article Source: https://www.marijuanamoment.net/utah-medical-marijuana-campaign-funding-slows-down-following-compromise-deal/

Comments

Popular posts from this blog

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...